Revvityブログ
発見から治療までのイノベーションを促進
 
     
    
            
        Latest
      
    
    Optimizing functional genomics research tools by aligning their design with the ongoing evolution of the genome.
Functional Genomic Screening 
October 30, 2025  -  3  min read
       
      Biologics
        Challenges and strategies for characterization of next-generation bispecific antibodies.
            May 24, 2024 -
            3 min read
          
          
         
       
      Disease Research
        Understanding how pre-clinical models impact immuno-oncology therapeutics.
            May 21, 2024 -
            2 min read
          
          
         
      Disease Research
        Understanding – and fighting against – immunotherapy resistance in cancer treatments.
            May 21, 2024 -
            2 min read
          
          
         
      Disease Research
        Synaptotagmin 7: a key player in synaptic function and plasticity.
            May 21, 2024 -
            2 min read
          
          
         
      Disease Research, Neuroscience Research
        In Vitro 3D cellular model shows promise in understanding rare pediatric neurodegenerative disease.
            May 21, 2024 -
            3 min read
          
          
         
      Disease Research
        Improving our understanding of biofilm formation on indwelling medical devices.
            May 21, 2024 -
            1 min read
          
          
         
       
      Disease Research, Neuroscience Research, Biomarker Detection
        Biomarkers: a novel approach to understanding dementia.
            May 21, 2024 -
            3 min read
          
          
         
      Disease Research, Neuroscience Research
        Big possibilities for small RNAs in the treatment of neurodegenerative diseases.
            May 21, 2024 -
            2 min read
          
          
         
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                  